Lead optimization in drug discovery (2022)
- Authors:
- USP affiliated authors: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP ; FRANCISCHINI, ISAQUE ANTONIO GALINDO - FCFRP ; BARCELOS, MARIANA PEGRUCCI - FCFRP ; GOMES, SUZANE QUINTANA - FFCLRP ; SILVA, GUILHERME MARTINS DA - FFCLRP
- Unidades: FCFRP; FFCLRP
- DOI: 10.1007/978-3-031-07622-0_19
- Subjects: PLANEJAMENTO DE FÁRMACOS; LEAD; QUÍMICA FARMACÊUTICA; LIGANTES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Research topics in bioactivity, environment and energy: experimental and theoretical tools
- Volume/Número/Paginação/Ano: 734 p
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BARCELOS, Mariana Pegrucci et al. Lead optimization in drug discovery. Research topics in bioactivity, environment and energy: experimental and theoretical tools. Tradução . Cham: Springer, 2022. . Disponível em: https://doi.org/10.1007/978-3-031-07622-0_19. Acesso em: 27 abr. 2024. -
APA
Barcelos, M. P., Gomes, S. Q., Federico, L. B., Francischini, I. A. G., Melim, L. I. da S. H., Silva, G. M. da, & Silva, C. H. T. de P. da. (2022). Lead optimization in drug discovery. In Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer. doi:10.1007/978-3-031-07622-0_19 -
NLM
Barcelos MP, Gomes SQ, Federico LB, Francischini IAG, Melim LI da SH, Silva GM da, Silva CHT de P da. Lead optimization in drug discovery [Internet]. In: Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer; 2022. [citado 2024 abr. 27 ] Available from: https://doi.org/10.1007/978-3-031-07622-0_19 -
Vancouver
Barcelos MP, Gomes SQ, Federico LB, Francischini IAG, Melim LI da SH, Silva GM da, Silva CHT de P da. Lead optimization in drug discovery [Internet]. In: Research topics in bioactivity, environment and energy: experimental and theoretical tools. Cham: Springer; 2022. [citado 2024 abr. 27 ] Available from: https://doi.org/10.1007/978-3-031-07622-0_19 - Potential colchicine binding site inhibitors unraveled by virtual screening, molecular dynamics and MM/PBSA
- Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening
- Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19
- Structural aspects of organic compounds as proteasome inhibitors addressed to several diseases
- Key aspects for achieving hits by virtual screening studies
- Chromatographic profile, in silico and in vivo study of the pharmacokinetic and toxicological properties of major constituent present in kefir, the kefiran
- Molecular docking, physicochemical properties, pharmacokinetics and toxicity of flavonoids present in Euterpe oleracea Martius
- Theoretical study of monoamine oxidase B inhibitors as drug candidates for treatment of Parkinson’s disease
- Hierarchical virtual screening based on rocaglamide derivatives to discover new potential anti-skin cancer agents
- Revisiting the proposition of binding pockets and bioactive poses for GSK-3β allosteric modulators addressed to neurodegenerative diseases
Informações sobre o DOI: 10.1007/978-3-031-07622-0_19 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003143984.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
